> https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-ordered-pay-1765-mln-teva-us-migraine-drug-patent-trial-2022-11-09/ https://www.reuters.

> https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-ordered-pay-1765-mln-teva-us-migraine-drug-patent-trial-2022-11-09/ https://www.reuters.com/business/healthcare-pharmaceuticals/... They also lose a lawsuit on the day of that tweet (and the drop was pretty typical for that day on the market) so I'm not really convinced their stock was altered much by a fake tweet.